Introduction: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is
associated with a unique set of implant challenges and barriers to wider adoption. Some of these barriers include the frequent use of general anesthesia (GA) and significant postoperative pain; and unlike transvenous ICD implantation, adequate analgesia routinely cannot be achieved with local anesthetic infiltration alone. 2 The main advantage of using GA for S-ICD implantation is for alleviating the intraoperative discomfort associated with the incision and dissection in the highly innervated midaxillary chest wall and tunneling of the parasternal subcutaneous lead.
However, there are disadvantages in the routine use of GA for S-ICD implantation, including hemodynamic compromise, the typical risks related to endotracheal intubation, as well as patient discomfort due to nausea and vomiting frequently seen in patients undergoing GA.
Furthermore, the resources required for GA may not be routinely readily available in some centers. [3] [4] [5] Postoperative analgesia usually consists of opioids; however, their use is associated with substantial short-and long-term morbidity. 6 Additionally, the efficacy of opioids for postoperative incisional acute pain control is suboptimal and substantial discomfort can persist after S-ICD implantation. 7, 8 Accordingly, there has been an increased interest in multimodal pain management strategies that adequately address perioperative/postoperative pain control with minimal narcotic use. Indeed, for a variety of surgical procedures across specialties, there has been a paradigm shift in pain management toward strategies that promote the use of opioid-sparing multimodal analgesia. [9] [10] [11] [12] [13] Herein, we report on the feasibility of performing S-ICD implantation under deep sedation (DS) using a multimodal analgesia regimen, which included truncal plane block (TBL).
| MATERIALS AND METHODS
This is a retrospective analysis of patients who underwent implantation of the S-ICD at the Mount Sinai Medical Center (New York, NY).
All procedures were performed after written informed consent was obtained from patients according to the institutional guidelines. The study was approved by the institutional review board.
2.1 | Perioperative anesthesia and analgesia
| GA + TBL
GA with endotracheal intubation was induced and maintained as per the practice of the attending anesthesiologist covering the case.
Following intubation, two ultrasound-guided TBL were performed, the (i) serratus anterior plane block (SAPB) and the (ii) transversus F I G U R E 1 Anesthetic and analgesic protocols for S-ICD implantation. DS + TBL, deep sedation plus truncal plane blocks; GA + TBL, general anesthesia plus truncal plane blocks; S-ICD, subcutaneous implantable-cardioverter defibrillator thoracic muscle plane block (TTPB) ( Figure 1A ). 14, 15 The SAPB is designed to target the lateral cutaneous branches of the intercostal nerves to provide analgesia for the anterolateral hemithorax (location of pulse generator), whereas the TTPB is designed to target the anterior branches of the intercostal nerves to provide analgesia along the sternum (location of the defibrillator lead). Table 1 contains the equipment and steps for the SAPB and TTPB. 
| Deep sedation and truncal plane blocks (DS + TBL)
Before entering the operating room, patients were pre-treated with oral acetaminophen (1000 mg) and gabapentin (600 mg), which were typically given 30 to 60 minutes before the procedure ( Figure 1B ).
After sedation was initiated with continuous propofol and dexmedetomidine infusion, the TBL were performed with ultrasound guidance, as 
| Subcutaneous ICD implant
As per our usual practice, if the patient was taking antiplatelet agents (aspirin and/or clopidogrel), the medication was continued uninterrupted. If the patient was on warfarin, it was held for 3 to 4 days before the implant. If the patient was on a nonwarfarin anticoagulant, it was held for at least 2 to 3 doses. Brief fluoroscopy was used to identify landmarks before the S-ICD implant. The landmarks were established after the truncal blocks were performed. Figure 5 demonstrates the final locations of the planned implant site and the incision locations (based on fluoroscopy) in relation to where the truncal blocks had been performed. The pulse generator was implanted below the serratus anterior fascia (subfascial) and a three-incision technique was used in all patients, as previously described. 16, 17 Invasive hemodynamic monitoring (radial arterial) was performed at the discretion of the anesthesiologist. A chest X-ray was routinely performed the day after implant.
| Outcomes
Procedure duration was defined as the time transpiring between anesthesia start-time to anesthesia end-time. Total perioperative opioid consumption was defined as the sum of opioids administered to the patient in the operating room, recovery area and in the hospital over 24 hours or at discharge (whichever came first). Total opioid consumption was converted to oral morphine equivalents using the following formula: intravenous fentanyl (μg) x 0. Serratus anterior plane block (SAPB):
Step 1: Place the ultrasound probe in the mid-axillary line (transverse plane) at the level of T4-T5
Step 2: Identify the relevant anatomy, specifically the latissimus dorsi (superficial and posterior) and the serratus anterior muscle (deeper and inferior), and then advance needle the needle (in-plane technique) in an anterior to posterior direction till the fascial plane is reached
Step 3: Inject a test dose of saline (3-5 mL) to confirm the correct location of needle tip
Step 4: Inject 20 mL of long-acting anesthetic (0.25% bupivacaine) into the fascial plane
Transversus thoracic muscle plane block (TTPB):
Step 1: Place the ultrasound probe on the left parasternal border at the T3-T4 level
Step 2: Identify relevant anatomy and then advance the needle (in-plane technique) to the space between the transversus thoracic muscle and the intercostal muscle between the ribs connecting to the sternum
Step 3: Inject a test dose of saline (3-5 mL) to confirm the correct location of the needle tip
Step 4: Inject 20 mL of long-acting anesthetic (0.25% bupivacaine) in between the muscles MILLER ET AL.
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x 7.5]. 17, 18 The doses are expressed as milligram morphine equivalents (MME).
| Statistical analysis
Continuous data were tested for normality and reported as means ± standard deviation or medians with the corresponding quartiles (25% and 75%) when appropriate and compared between more than two groups using the Kruskal-Wallis test. 
| RESULTS
As shown in Table 2 , baseline characteristics were similar in the three groups. Specifically, there were no significant differences in age, sex, body mass index, left ventricular ejection fraction, primary prevention indication for implant, ischemic cardiomyopathy, or presence of endstage renal disease requiring dialysis. Volatile anesthetics were used for maintenance of anesthesia in all GA + TBL patients and higher doses of propofol were used for maintenance in the DS + TBL patients. There were no significant differences between the two groups in procedure duration or postoperative day of discharge.
F I G U R E 3
Injection site and the corresponding ultrasound image obtained during TTPB. A, Ultrasound transducer and location of needle insertion. B, C, Advancement of the needle (arrows) under ultrasound guidance thru the PM into the space between the ICM and the TTM and injection of anesthetic. ICM, intercostal muscle; PM, pectoralis major; TTC, transverse thoracic muscle; TTM, transverse thoracic muscle; TTPB, transverse thoracic plane block F I G U R E 2 Serratus anterior plane block demonstrating the injection site on the chest wall and the corresponding ultrasound images of the injection above and below the serratus anterior muscle. The red star denotes a space filled with a local long-acting anesthetic. Ld, latissimus dorsi; Sa, serratus anterior; R, rib; US, ultrasound
In the first 12 hours, opioid consumption was significantly lower in the patients that were implanted with DS + TBL (MME = 0), as compared with patients that were implanted with GA + TBL (MME = 45; P = 0.003) (Table 3 and Figure 6 ). Total opioid consumption by 24 hours (or discharge) was significantly lower in the DS + TBL patients (cohort 3, MME = 0), as compared with GA + TBL (MME = 60; P = 0.004); this was mostly driven by opioid use during the first 12 hours.
There were no significant differences between the three groups in procedure duration or postoperative day of discharge.
There were no readmissions to the hospital in the first 4 weeks, no complications such as hematoma that required intervention or prolongation of hospital stay, and no device-related infections that required intervention or antibiotics in any of the groups.
| DISCUSSION
To our knowledge, this is the first demonstration of an anesthetic regimen that combines opioid-free anesthesia with DS for S-ICD implantation. Our findings are clinically relevant, since routine use of GA during S-ICD implantation can be associated with anesthesia related risks, and there has been increasing interest in transitioning away from GA and towards deep (conscious) sedation for S-ICD implantation.
Furthermore, since S-ICD implantation is associated with more pain than that with conventional transvenous ICD implants, it would be prudent to develop strategies for controlling postoperative pain while minimizing narcotic use. Even the short-term use of opioids can be associated with substantial short-and long-term morbidity. 6 To meet both these goals, we decided to incorporate strategies such as regional anesthesia and structured administration of nonopioid analgesics before, during, and after the procedure.
The first change we incorporated was the routine use of two recently described TBL, which have been used to provide analgesia for a variety of chest wall procedures and appear to have an excellent analgesic and safety profile. 18, 19 The SAPB targets the lateral cutaneous branches of the intercostal nerves to block the sensory dermatomes of T2-T9 of the hemithorax. The TTPB is designed to block the sensory dermatomes Th two to six by affecting the anterior We then decided to incorporate additional preoperative and postoperative strategies that have been successfully used in enhanced recovery after surgery protocols. 20 Specifically, based on the evidence that the single-dose of gabapentin and acetaminophen may reduce opioid consumption, we administered these medication in the holding area, before the procedure. 21 Ketorolac is also known to have an opioid sparing effect, and patients were administered 
| Limitations
An obvious limitation of the TBL technique is that it is an extrastep in the procedure, and anesthesiologists need to be trained in the technique. This was a retrospective analysis comparing different anesthetic and analgesic strategies. There is the possibility of placebo effect, since patients were informed that they would be receiving TBL, and therefore they may have 
